Status:
UNKNOWN
Lesion Contiguity in Very High Power-short Duration Ablation
Lead Sponsor:
University of Barcelona
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
This observational trial investigates the effect of very high power-short duration radiofrequency ablation on lesion contiguity as assessed by late gadolinium enhancement cardiovascular magnetic reson...
Eligibility Criteria
Inclusion
- paroxysmal or early persistent (max. 3 months) atrial fibrillation
- scheduled for PVI-only catheter ablation
Exclusion
- long-standing persistent atrial fibrillation
- previous left atrial ablation
- claustrophobia preventing CMR
- sever renal insufficiency (GFR \>30 ml/min)
- gadolinium contrast allergy
- presence of implantable devices not compatible with magnetic resonance
- pregnancy and lactation
Key Trial Info
Start Date :
March 10 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT05368610
Start Date
March 10 2022
End Date
June 1 2023
Last Update
May 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Clinic, University of Barcelona
Barcelona, Catalonia, Spain, 08036